{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:08:41Z","timestamp":1789560521333,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-10636-9","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T13:27:56Z","timestamp":1740490076000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clinical presentation and outcomes of bloodstream infection with intrinsically carbapenem-resistant non-fermenting gram-negative organisms: Stenotrophomonas maltophilia, Elizabethkingia spp. and Chryseobacterium spp. in Singapore, from 2012 to 2024"],"prefix":"10.1186","volume":"25","author":[{"given":"Matthew Chung Yi","family":"Koh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghao Nicholas","family":"Ngiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Lip","family":"Chew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nares","family":"Smitasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel Hon-Wai","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Michael","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"12","key":"10636_CR1","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.3390\/microorganisms10122506","volume":"10","author":"TA Hafiz","year":"2022","unstructured":"Hafiz TA, Aldawood E, Albloshi A, et al. Stenotrophomonas maltophilia Epidemiology, Resistance Characteristics, and clinical outcomes: understanding of the recent three years\u2019 trends. Microorganisms. 2022;10(12):2506. https:\/\/doi.org\/10.3390\/microorganisms10122506.","journal-title":"Microorganisms"},{"key":"10636_CR2","doi-asserted-by":"publisher","first-page":"808391","DOI":"10.3389\/fmed.2021.808391","volume":"8","author":"N Wang","year":"2021","unstructured":"Wang N, Tang C, Wang L. Risk factors for Acquired Stenotrophomonas maltophilia Pneumonia in Intensive Care Unit: a systematic review and Meta-analysis. Front Med (Lausanne). 2021;8:808391. https:\/\/doi.org\/10.3389\/fmed.2021.808391.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"10636_CR3","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3201\/eid2501.171985","volume":"25","author":"MH Choi","year":"2019","unstructured":"Choi MH, Kim M, Jeong SJ, et al. Risk factors for Elizabethkingia Acquisition and clinical characteristics of patients, South Korea. Emerg Infect Dis. 2019;25(1):42\u201351. https:\/\/doi.org\/10.3201\/eid2501.171985.","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10636_CR4","doi-asserted-by":"publisher","first-page":"000594v3","DOI":"10.1099\/acmi.0.000594.v3","volume":"5","author":"R Chaudhary","year":"2023","unstructured":"Chaudhary R, Kar M, Jamwal A, et al. Characteristics of Chryseobacterium bacteremia, associated risk factors and their antibiotic susceptibility pattern at a university hospital: a descriptive, retrospective study. Access Microbiol. 2023;5(11):000594v3. https:\/\/doi.org\/10.1099\/acmi.0.000594.v3.","journal-title":"Access Microbiol"},{"issue":"1","key":"10636_CR5","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/cid\/cix1052","volume":"67","author":"EJ Dziuban","year":"2018","unstructured":"Dziuban EJ, Franks JL, So M, Peacock G, Blaney DD. Elizabethkingia in children: a comprehensive review of symptomatic cases reported from 1944 to 2017. Clin Infect Dis. 2018;67(1):144\u20139. https:\/\/doi.org\/10.1093\/cid\/cix1052.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10636_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.2169\/internalmedicine.56.6141","volume":"56","author":"H Ebara","year":"2017","unstructured":"Ebara H, Hagiya H, Haruki Y, Kondo E, Otsuka F. Clinical characteristics of Stenotrophomonas maltophilia bacteremia: a Regional Report and a review of a Japanese Case Series. Intern Med. 2017;56(2):137\u201342. https:\/\/doi.org\/10.2169\/internalmedicine.56.6141.","journal-title":"Intern Med"},{"issue":"9","key":"10636_CR7","doi-asserted-by":"publisher","first-page":"e0109421","DOI":"10.1128\/JCM.01094-21","volume":"59","author":"DD Rhoads","year":"2021","unstructured":"Rhoads DD. Stenotrophomonas maltophilia Susceptibility Testing challenges and strategies. J Clin Microbiol. 2021;59(9):e0109421. https:\/\/doi.org\/10.1128\/JCM.01094-21.","journal-title":"J Clin Microbiol"},{"key":"10636_CR8","doi-asserted-by":"crossref","unstructured":"Pranita D, Tamma EL, Heil JA, Justo AJ, Mathers MJ, Satlin RA, Bonomo. Infectious Diseases Society of America Antimicrobial-Resistant Treatment Guidance: Gram-Negative Bacterial Infections. Infectious Diseases Society of America 2024; Version 4.0. Available at https:\/\/www.idsociety.org\/practice-guideline\/amr-guidance\/. Accessed 14\/07\/2024.","DOI":"10.1093\/cid\/ciae403"},{"issue":"5","key":"10636_CR9","doi-asserted-by":"publisher","first-page":"882","DOI":"10.3390\/microorganisms10050882","volume":"10","author":"A Zajmi","year":"2022","unstructured":"Zajmi A, Teo J, Yeo CC. Epidemiology and characteristics of Elizabethkingia Spp. Infections in Southeast Asia. Microorganisms. 2022;10(5):882. https:\/\/doi.org\/10.3390\/microorganisms10050882.","journal-title":"Microorganisms"},{"key":"10636_CR10","doi-asserted-by":"publisher","unstructured":"AlFonaisan MK, Mubaraki MA, Althawadi SI, et al. Temporal analysis of prevalence and antibiotic-resistance patterns in Stenotrophomonas maltophilia clinical isolates in a 19-year retrospective study. Sci Rep. 2024;14(1). https:\/\/doi.org\/10.1038\/s41598-024-65509-z.","DOI":"10.1038\/s41598-024-65509-z"},{"issue":"10","key":"10636_CR11","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s10096-011-1223-0","volume":"30","author":"MS Hsu","year":"2011","unstructured":"Hsu MS, Liao CH, Huang YT, et al. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999\u20132006. Eur J Clin Microbiol Infect Dis. 2011;30(10):1271\u20138. https:\/\/doi.org\/10.1007\/s10096-011-1223-0.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10636_CR12","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1128\/jcm.42.1.445-448.2004","volume":"42","author":"JT Kirby","year":"2004","unstructured":"Kirby JT, Sader HS, Walsh TR, Jones RN. Antimicrobial susceptibility and epidemiology of a Worldwide Collection of Chryseobacterium spp.: Report from the SENTRY Antimicrobial Surveillance Program (1997\u20132001). J Clin Microbiol. 2004;42(1):445\u20138. https:\/\/doi.org\/10.1128\/jcm.42.1.445-448.2004.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10636_CR13","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3390\/medicina60010162","volume":"60","author":"C Huang","year":"2024","unstructured":"Huang C, Kuo S, Lin L. Hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in patients with hematologic Malignancies\u2014A systematic review and Meta-analysis. Medicina. 2024;60(1):162. https:\/\/doi.org\/10.3390\/medicina60010162.","journal-title":"Medicina"},{"issue":"8","key":"10636_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jiac.2018.03.011","volume":"24","author":"K Osawa","year":"2018","unstructured":"Osawa K, Shigemura K, Kitagawa K, Tokimatsu I, Fujisawa M. Risk factors for death from Stenotrophomonas maltophilia bacteremia. J Infect Chemother. 2018;24(8):632\u20136. https:\/\/doi.org\/10.1016\/j.jiac.2018.03.011.","journal-title":"J Infect Chemother"},{"key":"10636_CR15","unstructured":"EUCAST: European Committee on Antimicrobial Susceptibility Testing. Clinical breakpoints - breakpoints and guidance. https:\/\/www.eucast.org\/clinical_breakpoints (Date Accessed 19\/7\/2024)."},{"issue":"5","key":"10636_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/antibiotics12050910","volume":"12","author":"AE Maraolo","year":"2023","unstructured":"Maraolo AE, Licciardi F, Gentile I, Saracino A, Belati A, Bavaro DF. Stenotrophomonas maltophilia infections: a systematic review and Meta-analysis of comparative efficacy of available treatments, with critical Assessment of Novel Therapeutic options. Antibiot (Basel). 2023;12(5):910. https:\/\/doi.org\/10.3390\/antibiotics12050910.","journal-title":"Antibiot (Basel)"},{"issue":"Pt 11","key":"10636_CR17","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1099\/jmm.0.076513-0","volume":"63","author":"A De Mauri","year":"2014","unstructured":"De Mauri A, Torreggiani M, Chiarinotti D, Andreoni S, Molinari G, De Leo M. Stenotrophomonas maltophilia: an emerging pathogen in dialysis units. J Med Microbiol. 2014;63(Pt 11):1407\u201310. https:\/\/doi.org\/10.1099\/jmm.0.076513-0.","journal-title":"J Med Microbiol"},{"issue":"3","key":"10636_CR18","doi-asserted-by":"publisher","first-page":"848","DOI":"10.4269\/ajtmh.20-1035","volume":"104","author":"VF Diniz Rocha","year":"2020","unstructured":"Diniz Rocha VF, Cavalcanti TP, Azevedo J, et al. Outbreak of Stenotrophomonas maltophilia and Burkholderia cepacia Bloodstream Infections at a Hemodialysis Center. Am J Trop Med Hyg. 2020;104(3):848\u201353. https:\/\/doi.org\/10.4269\/ajtmh.20-1035.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10636_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.5009\/gnl.2013.7.2.228","volume":"7","author":"MS Kwak","year":"2013","unstructured":"Kwak MS, Jang ES, Ryu JK, Kim YT, Yoon YB, Park JK. Risk factors of post endoscopic retrograde cholangiopancreatography bacteremia. Gut Liver. 2013;7(2):228\u201333. https:\/\/doi.org\/10.5009\/gnl.2013.7.2.228.","journal-title":"Gut Liver"},{"issue":"9","key":"10636_CR20","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3390\/microorganisms7090295","volume":"7","author":"JN Lin","year":"2019","unstructured":"Lin JN, Lai CH, Yang CH, Huang YH. Elizabethkingia Infections in humans: from Genomics to Clinics. Microorganisms. 2019;7(9):295. https:\/\/doi.org\/10.3390\/microorganisms7090295.","journal-title":"Microorganisms"},{"issue":"4","key":"10636_CR21","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/gb-2008-9-4-r74","volume":"9","author":"LC Crossman","year":"2008","unstructured":"Crossman LC, Gould VC, Dow JM, et al. The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants. Genome Biol. 2008;9(4):R74. https:\/\/doi.org\/10.1186\/gb-2008-9-4-r74.","journal-title":"Genome Biol"},{"issue":"4","key":"10636_CR22","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/14787210.2020.1730178","volume":"18","author":"T Gil-Gil","year":"2020","unstructured":"Gil-Gil T, Mart\u00ednez JL, Blanco P. Mechanisms of antimicrobial resistance in Stenotrophomonas maltophilia: a review of current knowledge. Expert Rev Anti Infect Ther. 2020;18(4):335\u201347. https:\/\/doi.org\/10.1080\/14787210.2020.1730178.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10636_CR23","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4314\/ahs.v16i1.20","volume":"16","author":"A \u00c7\u0131kman","year":"2016","unstructured":"\u00c7\u0131kman A, Parlak M, Bayram Y, G\u00fcd\u00fcc\u00fco\u011flu H, Berkta\u015f M. Antibiotics resistance of Stenotrophomonas maltophilia strains isolated from various clinical specimens. Afr Health Sci. 2016;16(1):149\u201352. https:\/\/doi.org\/10.4314\/ahs.v16i1.20.","journal-title":"Afr Health Sci"},{"issue":"1","key":"10636_CR24","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1128\/AAC.00795-06","volume":"51","author":"A Okazaki","year":"2007","unstructured":"Okazaki A, Avison MB. Aph(3\u2032)-IIc, an Aminoglycoside Resistance Determinant from Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2007;51(1):359\u201360. https:\/\/doi.org\/10.1128\/AAC.00795-06.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10636_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1128\/AAC.01020-12","volume":"57","author":"VC Gould","year":"2013","unstructured":"Gould VC, Okazaki A, Avison MB. Coordinate hyperproduction of SmeZ and SmeJK efflux pumps extends Drug Resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2013;57(1):655\u20137. https:\/\/doi.org\/10.1128\/AAC.01020-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"10636_CR26","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.3389\/fmicb.2019.01191","volume":"10","author":"N Bostanghadiri","year":"2019","unstructured":"Bostanghadiri N, Ghalavand Z, Fallah F, et al. Characterization of phenotypic and genotypic diversity of Stenotrophomonas maltophilia strains isolated from selected hospitals in Iran. Front Microbiol. 2019;10:1191. https:\/\/doi.org\/10.3389\/fmicb.2019.01191.","journal-title":"Front Microbiol"},{"issue":"7","key":"10636_CR27","doi-asserted-by":"publisher","first-page":"4347","DOI":"10.1128\/AAC.00714-15","volume":"59","author":"MB S\u00e1nchez","year":"2015","unstructured":"S\u00e1nchez MB, Mart\u00ednez JL. The Efflux Pump SmeDEF contributes to Trimethoprim-Sulfamethoxazole Resistance in Stenotrophomonas maltophilia. Antimicrob Agents Chemother. 2015;59(7):4347\u20138. https:\/\/doi.org\/10.1128\/AAC.00714-15.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10636_CR28","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/jac\/dkz045","volume":"74","author":"MJ Jian","year":"2019","unstructured":"Jian MJ, Cheng YH, Chung HY, et al. Fluoroquinolone resistance in carbapenem-resistant Elizabethkingia anophelis: phenotypic and genotypic characteristics of clinical isolates with topoisomerase mutations and comparative genomic analysis. J Antimicrob Chemother. 2019;74(6):1503\u201310. https:\/\/doi.org\/10.1093\/jac\/dkz045.","journal-title":"J Antimicrob Chemother"},{"key":"10636_CR29","doi-asserted-by":"publisher","unstructured":"Zhang L, Wang M, Qi R, et al. A novel major facilitator superfamily-type tripartite efflux system CprABC mediates resistance to polymyxins in Chryseobacterium sp. PL22-22A. Front Microbiol. 2024;15. https:\/\/doi.org\/10.3389\/fmicb.2024.1346340.","DOI":"10.3389\/fmicb.2024.1346340"},{"issue":"12","key":"10636_CR30","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.3390\/antibiotics11121788","volume":"11","author":"A Prawang","year":"2022","unstructured":"Prawang A, Chanjamlong N, Rungwara W, et al. Combination therapy versus Monotherapy in the treatment of Stenotrophomonas maltophilia infections: a systematic review and Meta-analysis. Antibiotics. 2022;11(12):1788. https:\/\/doi.org\/10.3390\/antibiotics11121788.","journal-title":"Antibiotics"},{"issue":"1","key":"10636_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13613-023-01144-7","volume":"13","author":"L Chen","year":"2023","unstructured":"Chen L, Hua J, Hong S, et al. Assessment of the relative benefits of monotherapy and combination therapy approaches to the treatment of hospital-acquired Stenotrophomonas maltophilia pneumonia: a multicenter, observational, real-world study. Ann Intensive Care. 2023;13(1):47. https:\/\/doi.org\/10.1186\/s13613-023-01144-7.","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10636_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/599376","volume":"49","author":"LA Mermel","year":"2009","unstructured":"Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1\u201345. https:\/\/doi.org\/10.1086\/599376.","journal-title":"Clin Infect Dis"},{"key":"10636_CR33","doi-asserted-by":"publisher","unstructured":"Chew KL, Cheng B, Lin RTP, Teo JWP. Elizabethkingia anophelis Is the Dominant Elizabethkingia Species Found in Blood Cultures in Singapore. Richter SS, ed. J Clin Microbiol. 2018;56(3):e01445-17. https:\/\/doi.org\/10.1128\/JCM.01445-17","DOI":"10.1128\/JCM.01445-17"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10636-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-10636-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-10636-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T13:27:59Z","timestamp":1740490079000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-10636-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10636"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-10636-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"21 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the hospital\u2019s institutional review board (National Healthcare Group (NHG) Domain Specific Review Board (DSRB) 2024\u20133132). A waiver of written informed consent was obtained from the hospital\u2019s institutional review board (National Healthcare Group (NHG) Domain Specific Review Board (DSRB) 2024\u20133132) prior to conduct. The study was carried out in accordance with the principles laid out by the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Clinical trial number: not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}],"article-number":"273"}}